G3T Competitors and Similar CompaniesClear all

Recursion Pharmaceuticals's competitors and similar companies include Strategic Partners.
Recursion Pharmaceuticals
Recursion Pharmaceuticals
Recursion Pharmaceuticals is a company that offers drug discovery and treatments using artificial intelligence, automation, bioinformatics, and experimental biology.
Strategic Partners
Strategic Partners
Strategic Partners (formerly known as Orphazyme) is a company that forms partnerships with biotech, industrial, commercial, property, and asset management companies.
Founding Date
Founding Date
2013
Founding Date
2009
Type
Type
Public
Type
Public
Tags
Locations
Locations
Salt Lake City, US HQ
Locations
København, DK HQ
Chicago, US
Newton, US
Employees
Employees
216
Employees
1
Valuation ($)
Valuation ($)
2 b
Valuation ($)
6.8 m

Financial

Revenue (est.)
Revenue (est.)
$74.7m (FY, 2025)
Revenue (est.)
kr309k (FY, 2025)
Cost of goods
Cost of goods
$71m (FY, 2025)
Cost of goods
N/A
Gross profit
Gross profit
$3.7m (FY, 2025)
Gross profit
kr309k (FY, 2025)
Net income
Net income
($644.8m) (FY, 2025)
Net income
(kr859k) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 437.1m
Total funding raised
$ 58.8m
For sources of this data, please see the company profile

View Company Profiles

Strategic Partners
HQ
København, DK
Employees
1

Strategic Partners (formerly known as Orphazyme) is a company that forms partnerships with biotech, industrial, commercial, property, and asset management companies.

View company